JENNIFER VANDIVIER: Open Payments
NPI 1205506557 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 6 companies in 2025. Trend: 2023 $671 · 2024 $347 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $38 |
| Corium, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, Qelbree, REXULTI, Azstarys, TRINTELLIX, Jornay PM.
Industry payments across IN — which companies pay providers there.
